Studies have reported that increased expression and overexpression of Grb2 relate to poor prognosis in patients with gastric cancer and lymph node metastasis and poor survival in esophageal cancer patients, respectively [64,65]. The gene discussed is GRB2; the disease is esophageal cancer.